The DOI matches its Crossref record; 249 of the 249 references it cites were found in a registry or an index.
The complexity of the Nrf2 pathway: beyond the antioxidant response
Open accessAbstract
The NF-E2-related factor 2 (Nrf2)-mediated signaling pathway provides living organisms an efficient and pivotal line of defensive to counteract environmental insults and endogenous stressors. Nrf2 coordinates the basal and inducible expression of antioxidant and phase II detoxification enzymes to adapt to different stress conditions. The stability and cellular distribution of Nrf2 is tightly controlled by its inhibitory binding protein Kelch-like ECH-associated protein 1 (Keap1). Nrf2 signaling is also regulated by post-translational, transcriptional, translational and epigenetic mechanisms, as well as by other protein partners, including p62, p21 and IQ motif-containing GTPase activating protein 1 (IQGAP1). Many studies have demonstrated that Nrf2 is a promising target for preventing carcinogenesis and other chronic diseases, including cardiovascular diseases, neurodegenerative diseases, and pulmonary injury. However, constitutive activation of Nrf2 in advanced cancer cells may confer drug resistance. Here, we review the molecular mechanisms of Nrf2 signaling, the diverse classes of Nrf2 activators, including bioactive nutrients and other chemicals and the cellular functions and disease relevance of Nrf2 and discuss the dual role of Nrf2 in different contexts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–249 of 249
Yu, R., Tan, T., & Kong, A.-N. T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.46.28962 · Cited by 116
Self-citationKeum, Y., Khor, T. O., Lin, W., Shen, G., Kwon, K. H., Barve, A., Li, W., & Kong, A. N. T. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9948-5 · Cited by 114
Self-citationDithiolethiones for cancer chemoprevention: where do we stand?
Zhang, Y., & Munday, R. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0625 · Cited by 114
Wang, X. J., Hayes, J. D., Higgins, L. G., Wolf, C. R., & Dinkova‐Kostova, A. T. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.12.013 · Cited by 113
Kinch, L. N., Grishin, N. V., & Brugarolas, J. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.10.005 · Cited by 111
DNA Methylation Pattern as Important Epigenetic Criterion in Cancer
Fakhr, M. G., Hagh, M. F., Shanehbandi, D., & Baradaran, B. (2013) · Genetics Research International · doi:10.1155/2013/317569 · Cited by 109
Rao, M. S. R., Nd, L., Tk, W., et al. (1984) · PubMed · Cited by 107
Abiko, Y., Miura, T., Phuc, B. H., Shinkai, Y., & Kumagai, Y. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.05.013 · Cited by 107
A review of dietary factors and its influence on DNA methylation in colorectal carcinogenesis
Arasaradnam, R. P., Commane, D. M., Bradburn, D., & Mathers, J. C. (2008) · Epigenetics · doi:10.4161/epi.3.4.6508 · Cited by 107
Primiano, T., Egner, P. A., Sutter, T. R., Kelloff, G. J., Roebuck, B. D., & Kensler, T. W. (1995) · PubMed · Cited by 105
Role of Nrf2 in Host Defense against Influenza Virus in Cigarette Smoke-Exposed Mice
Yageta, Y., Ishii, Y., Morishima, Y., Masuko, H., Ano, S., Yamadori, T., Itoh, K., Takeuchi, K., Yamamoto, M. P., & Hizawa, N. (2011) · Journal of Virology · doi:10.1128/jvi.02456-10 · Cited by 97
Wu, T., Khor, T. O., Su, Z., Saw, C. L. L., Shu, L., Cheung, K., Huang, Y. S., Yu, S., & Kong, A. T. (2013) · The AAPS Journal · doi:10.1208/s12248-013-9493-3 · Cited by 95
Self-citationKeap1 Cysteine 288 as a Potential Target for Diallyl Trisulfide-Induced Nrf2 Activation
Kim, S., Lee, H.-G., Park, S., Kundu, J. K., Keum, Y., Cha, Y., Na, H., & Surh, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085984 · Cited by 95
Clark, J., & Simon, D. K. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2241 · Cited by 95
Li, J., Zhang, C., Xing, Y., Janicki, J. S., Yamamoto, M. P., Wang, X. L., Tang, D., & Cui, T. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr010 · Cited by 94
Chemopreventive Functions of Isothiocyanates
Keum, Y., Jeong, W., & Kong, A. T. (2005) · Drug News & Perspectives · doi:10.1358/dnp.2005.18.7.939350 · Cited by 93
Self-citationNrf2 protects against As(III)-induced damage in mouse liver and bladder
Jiang, T., Huang, Z., Chan, J. Y., & Zhang, D. D. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.06.010 · Cited by 92
Ho, C.-Y., Cheng, Y., Chau, C., & Yen, G. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf203800d · Cited by 88
Nair, S., Barve, A., Khor, T.-O., Shen, G., Lin, W., Chan, J. Y., Cai, L., & Kong, A. T. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.147 · Cited by 85
Self-citationHistone deacetylase modulators provided by Mother Nature
Seidel, C., Schnekenburger, M., Dicato, M. A., & Diederich, M. F. (2012) · Genes & Nutrition · doi:10.1007/s12263-012-0283-9 · Cited by 82
Balstad, T. R., Carlsen, H., Myhrstad, M. C. W., Kolberg, M., Reiersen, H., Gilen, L., Ebihara, K., Paur, I., & Blomhoff, R. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201000204 · Cited by 82
Huang, Y. S., Khor, T. O., Shu, L., Saw, C. L. L., Wu, T., Suh, N., Yang, C. S., & Kong, A. T. (2012) · Journal of Nutrition · doi:10.3945/jn.111.153114 · Cited by 82
Self-citationNrf2 Overexpression Predicts Prognosis and 5-FU Resistance in Gastric Cancer
Hu, X., Yao, J., Gao, S., Wang, X., Peng, X.-Q., Yang, Y., & Feng, X. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.9.5231 · Cited by 82
Diagnostic heterogeneity in psychiatry: towards an empirical solution
Wardenaar, K. J., & de Jonge, P. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-201 · Cited by 81
Eggler, A. L., Luo, Y., van Breemen, R. B., & Mesecar, A. D. (2007) · Chemical Research in Toxicology · doi:10.1021/tx700217c · Cited by 80
Tang, C. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.924 · Cited by 80
Yang, G., Wang, Z.-J., Bai, F., Qin, X., Cao, J., Lv, J., & Zhang, M. (2015) · Molecules · doi:10.3390/molecules20046626 · Cited by 79
Yang, H., Magilnick, N., Ou, X., & Lu, S. C.-L. (2005) · Biochemical Journal · doi:10.1042/bj20050795 · Cited by 79
He, X., & Ma, Q. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.160465 · Cited by 79
NQO1 and NQO2 Regulation of Humoral Immunity and Autoimmunity
Iskander, K. S., Li, J. L., Han, S., Zheng, B. Q., & Jaiswal, A. K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605809200 · Cited by 76
Induction of the Keap1/Nrf2/ARE pathway by oxidizable diphenols
Dinkova‐Kostova, A. T., & Wang, X. J. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.09.010 · Cited by 70
Nair, S., Xu, C., Shen, G., Hebbar, V., Gopalakrishnan, A., Hu, R., Jain, M. R., Lin, W., Keum, Y.-S., Liew, C. V., et al. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9099-x · Cited by 68
Self-citationXi, Y., Yu, H., Ding, J., Ma, W., Yuan, L., Feng, J., Xiao, Y., & Xiao, R. (2012) · Current Neurovascular Research · doi:10.2174/156720212799297092 · Cited by 67
Anwar‐Mohamed, A., Degenhardt, O. S., Gendy, M. A. M. E., Seubert, J. M., Kleeberger, S. R., & El‐Kadi, A. O. S. (2011) · Toxicology in Vitro · doi:10.1016/j.tiv.2011.01.014 · Cited by 65
Dietary Cancer Chemopreventive Agents – Targeting Inflammation and Nrf2 Signaling Pathway
Khor, T. O., Yu, S., & Kong, A. T. (2008) · Planta Medica · doi:10.1055/s-0028-1088303 · Cited by 64
Self-citationLin, H., Wei, B., Li, G., Zheng, J., Sun, J., Chu, J., Zeng, R., & Niu, Y. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s65410 · Cited by 63
Select Heterozygous Keap1 Mutations Have a Dominant-Negative Effect on Wild-Type Keap1 In Vivo
Suzuki, T., Maher, J. M., & Yamamoto, M. P. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2939 · Cited by 55
Chemopreventive Promise of Targeting the Nrf2 Pathway
Yates, M. S., & Kensler, T. W. (2007) · Drug News & Perspectives · doi:10.1358/dnp.2007.20.2.1083437 · Cited by 53
Cheung, K. L., Lee, J. H., Shu, L., Kim, J. H., Sacks, D. B., & Kong, A. T. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.444182 · Cited by 51
Self-citationWang, Y., Liu, N., Su, X., Zhou, G., Sun, G., Du, F., Bian, X., & Wang, B. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.01.032 · Cited by 50
Nrf2 Activation Attenuates Both Orthodontic Tooth Movement and Relapse
Kanzaki, H., Shinohara, F., Itohiya-Kasuya, K., Ishikawa, M., & Nakamura, Y. (2015) · Journal of Dental Research · doi:10.1177/0022034515577814 · Cited by 48
Experimental Therapeutics of Nrf2 as a Target for Prevention of Bacterial Exacerbations in COPD
Biswal, S. S., Thimmulappa, R. K., & Harvey, C. J. (2012) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201201-009ms · Cited by 47
Kim, J. H., Xu, E. Y., Sacks, D. B., Lee, J. H., Shu, L., Xia, B., & Kong, A. T. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4586 · Cited by 42
Self-citationJun, C., Kim, Y., Choi, E.-Y., Kim, M. S., Park, B., Youn, B., Yu, K.-Y., Choi, K., Yoon, K., Choi, S. C., et al. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.ibd.0000225340.99108.8a · Cited by 33
Wang, H., Khor, T. O., Yang, Q., Huang, Y. S., Wu, T., Saw, C. L. L., Lin, W., Androulakis, I. P., & Kong, A. T. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300130k · Cited by 32
Self-citationHolland, R., Navamal, M., Velayutham, M., Zweier, J. L., Kensler, T. W., & Fishbein, J. C. (2009) · Chemical Research in Toxicology · doi:10.1021/tx900110n · Cited by 30
Jia, Z., Zhu, H., Trush, M. A., Misra, H. P., & Li, Y. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9598-z · Cited by 24
Díaz, M. F. F. P., Acosta, M., Mohamed, F., Ferramola, M. L., Oliveros, L. B., & Giménez, M. S. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.07.016 · Cited by 24
Karuri, A. R., Huang, Y., Bodreddigari, S., Sutter, C. H., Roebuck, B. D., Kensler, T. W., & Sutter, T. R. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.096396 · Cited by 21
Self-citation
Cited by
Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions
Qin, C., Yang, S., Chu, Y.-H., Zhang, H., Pang, X.-W., Chen, L., Zhou, L.-Q., Chen, M., Tian, D.-S., & Wang, W. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01064-1 · Cited by 939
Sivandzade, F., Prasad, S., Bhalerao, A., & Cucullo, L. (2019) · Redox Biology · doi:10.1016/j.redox.2018.11.017 · Cited by 639
Oxidative Stress: Signaling Pathways, Biological Functions, and Disease
Liu, S., Liu, J., Wang, Y., Deng, F., & Deng, Z. (2025) · MedComm · doi:10.1002/mco2.70268 · Cited by 359
Plasma Medicine: A Field of Applied Redox Biology
VON WOEDTKE, T., SCHMIDT, A., BEKESCHUS, S., WENDE, K., & WELTMANN, K.-D. (2019) · In Vivo · doi:10.21873/invivo.11570 · Cited by 318
The Role of Nrf2 Activity in Cancer Development and Progression
Zimta, A.-A., Cenariu, D., Irimie, A., Magdo, L., Nabavi, S. M., Atanasov, A. G., & Berindan-Neagoe, I. (2019) · Cancers · doi:10.3390/cancers11111755 · Cited by 292
Metadata
- Authors
- Huang, Y., Li, W., Su, Z.-Y., & Kong, A.-N. T.
- Venue
- The Journal of Nutritional Biochemistry
- Publisher
- Elsevier BV
- Published
- 2015-12
- Volume
- 26
- Issue
- 12
- Pages
- 1401-1413
- ISSN
- 0955-2863 (ISSN-L)
- OpenAlex
- W1231316025
- Cited by
- 445
- References
- 249
- FWCI
- 12.35
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.